Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells

Plastic and Reconstructive Surgery

Volumn 130, Issue 5, 2012, Pages 1012-1021

  Wong, Alvin ^a   Hardy, Krista L ^a   Kitajewski, Alex M ^a   Shawber, Carrie J ^a   Kitajewski, Jan K ^a   Wu, June K ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRB1 PROTEIN, HUMAN; ADRB2 PROTEIN, HUMAN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIPOCORTIN 5; PROPRANOLOL;

ADIPOGENESIS; APOPTOSIS; ARTICLE; BLOOD; CELL PROLIFERATION; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; FLOW CYTOMETRY; HEMANGIOMA; HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL;

ADIPOGENESIS; ADRENERGIC BETA-ANTAGONISTS; ANNEXIN A5; APOPTOSIS; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; FLOW CYTOMETRY; HEMANGIOMA; HUMANS; PROPRANOLOL; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; STEM CELLS;

EID: 84871727112     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318267d3db     Document Type: Article

References (19)

1. Frieden IJ, Haggstrom AN, Drolet BA, et al. Infantile hemangiomas: Current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7 to 9, 2005, Bethesda, Md. Pediatr Dermatol. 2005;22:383-406.
2. Haggstrom AN, Drolet BA, Baselga E, et al. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 2006;118:882-887.
3. Chamlin SL, Haggstrom AN, Drolet BA, et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr. 2007; 151:684-689.
4. Boon LM, Burrows PE, Paltiel HJ, et al. Hepatic vascular anomalies in infancy: A 27-year experience. J Pediatr. 1996; 129:346-354.
5. Arneja JS, Mulliken JB. Resection of amblyogenic periocular hemangiomas: Indications and outcomes. Plast Reconstr Surg. 2010;125:274-281.
6. Ceisler E, Blei F. Ophthalmic issues in hemangiomas of infancy. Lymphat Res Biol. 2003;1:321-330.
7. Schwartz SR, Blei F, Ceisler E, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. J AAPOS 2006;10:262-268.
8. Bitar MA, Moukarbel RV, Zalzal GH. Management of congenital subglottic hemangioma: Trends and success over the past 17 years. Otolaryngol Head Neck Surg. 2005;132: 226-231.
9. Grimmer JF, Mulliken JB, Burrows PE, et al. Radiofrequency ablation of microcystic lymphatic malformation in the oral cavity. Arch Otolaryngol Head Neck Surg. 2006;132: 1251-1256.
10. Khan ZA, Boscolo E, Picard A, et al. Multipotential hemangioma stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest. 2008;118: 2592-2599.
11. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propranolol for severe hemangiomas of infancy.NEngl J Med. 2008;358:2649-2651.
12. Lamy S LM, Lord-Dufour S, Béliveau R. Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of hemangioma endothelial cells. Vascul Pharmacol. 2010;53:200-208.
13. Annabi B, Lachambre MP, Plouffe K, et al. Propranolol adrenergic blockade inhibits human brain hemangioma endothelial cells tubulogenesis and matrix metalloproteinase-9 secretion. Pharmacol Res. 2009;60:438-445.
14. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:e45.
15. Sommers Smith SK, Smith DM. Beta blockade induces apoptosis in cultured capillary hemangioma endothelial cells. In Vitro Cell Dev Biol Anim. 2002;38:298-304.
16. Storch CH, Hoeger PH. Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action. Br J Dermatol. 2010;163:269-274.
17. Frieden IJ, Drolet BA. Propranolol for infantile hemangiomas: Promise, peril, pathogenesis. Pediatr Dermatol. 2009;26: 642-644.
18. Greenberger S, Boscolo E, Adini I, et al. Corticosteroid suppression of VEGF-A in infantile hemangioma-derived hemangioma stem cells. N Engl J Med. 2010;362:1005-1013.
19. North PE, Waner M, Mizeracki A, et al. GLUT1: A newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol. 2000;31:11-22.